These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 24320087)

  • 21. Current understanding of conventional outflow dysfunction in glaucoma.
    Stamer WD; Acott TS
    Curr Opin Ophthalmol; 2012 Mar; 23(2):135-43. PubMed ID: 22262082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guanylate cyclase activators, cell volume changes and IOP reduction.
    Ellis DZ
    Cell Physiol Biochem; 2011; 28(6):1145-54. PubMed ID: 22179003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Melatonin and the control of intraocular pressure.
    Alkozi HA; Navarro G; Franco R; Pintor J
    Prog Retin Eye Res; 2020 Mar; 75():100798. PubMed ID: 31560946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ciliary body ablation: where are we and how did we get here?
    Mastrobattista JM; Luntz M
    Surv Ophthalmol; 1996; 41(3):193-213. PubMed ID: 8970235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Indications and results of Sonocare (ultrasound) in the treatment of ocular hypertension. A preliminary study of 395 cases].
    Haut J; Colliac JP; Falque L; Renard Y
    Ophtalmologie; 1990; 4(2):138-41. PubMed ID: 2235002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of PF-04217329 a prodrug of a selective prostaglandin EP(2) agonist on intraocular pressure in preclinical models of glaucoma.
    Prasanna G; Carreiro S; Anderson S; Gukasyan H; Sartnurak S; Younis H; Gale D; Xiang C; Wells P; Dinh D; Almaden C; Fortner J; Toris C; Niesman M; Lafontaine J; Krauss A
    Exp Eye Res; 2011 Sep; 93(3):256-64. PubMed ID: 21376717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacotherapies for glaucoma.
    Toris CB
    Curr Mol Med; 2010 Dec; 10(9):824-40. PubMed ID: 21091423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of glaucoma: focus on pharmacological therapy.
    Marquis RE; Whitson JT
    Drugs Aging; 2005; 22(1):1-21. PubMed ID: 15663346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autonomic drugs in the treatment of canine and feline glaucoma--Part I: Medications that lower intraocular pressure by increasing the outflow of aqueous humour.
    Maślanka T
    Pol J Vet Sci; 2014; 17(4):741-52. PubMed ID: 25638993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of dopaminergic receptors in glaucomatous disease modulation.
    Pescosolido N; Parisi F; Russo P; Buomprisco G; Nebbioso M
    Biomed Res Int; 2013; 2013():193048. PubMed ID: 23878797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of the Rho GTPase/Rho kinase signaling pathway in pathogenesis and treatment of glaucoma: Bench to bedside research.
    Rao PV; Pattabiraman PP; Kopczynski C
    Exp Eye Res; 2017 May; 158():23-32. PubMed ID: 27593914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostaglandin pathway gene therapy for sustained reduction of intraocular pressure.
    Barraza RA; McLaren JW; Poeschla EM
    Mol Ther; 2010 Mar; 18(3):491-501. PubMed ID: 19953083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endogenous production of extracellular adenosine by trabecular meshwork cells: potential role in outflow regulation.
    Wu J; Li G; Luna C; Spasojevic I; Epstein DL; Gonzalez P
    Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):7142-8. PubMed ID: 22997289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo cAMP level in rabbit iris-ciliary body after topical epinephrine treatment.
    Liu JH; Gallar J
    Curr Eye Res; 1996 Oct; 15(10):1025-32. PubMed ID: 8921241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Effect of High-Intensity Focused Ultrasound on Aqueous Humor Dynamics in Patients with Glaucoma.
    Alaghband P; Galvis E; Ramirez A; Madekurozwa M; Chu B; Overby D; Lim KS
    Ophthalmol Glaucoma; 2020; 3(2):122-129. PubMed ID: 32672595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological management of ocular hypertension: current approaches and future prospective.
    Bucolo C; Salomone S; Drago F; Reibaldi M; Longo A; Uva MG
    Curr Opin Pharmacol; 2013 Feb; 13(1):50-5. PubMed ID: 23069477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Physiology of aqueous humor formation, diurnal fluctuation of intraocular pressure and its significance for glaucoma].
    Göbel K; Rüfer F; Erb C
    Klin Monbl Augenheilkd; 2011 Feb; 228(2):104-8. PubMed ID: 21328169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-21-5p: A viable therapeutic strategy for regulating intraocular pressure.
    Tan C; Song M; Stamer WD; Qiao Y; Chen X; Sun X; Lei Y; Chen J
    Exp Eye Res; 2020 Nov; 200():108197. PubMed ID: 32871166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnosis and treatment of ocular hypertension].
    Sun YY; Chen WW; Wang NL
    Zhonghua Yan Ke Za Zhi; 2016 Jul; 52(7):542-6. PubMed ID: 27531115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostaglandins mediate the stimulatory effects of endothelin-1 on cyclic adenosine monophosphate accumulation in ciliary smooth muscle isolated from bovine, cat, and other mammalian species.
    Abdel-Latif AA; Yousufzai SY; el-Mowafy AM; Ye Z
    Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):328-38. PubMed ID: 8603837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.